Osteoarthritis (OA) is a persistent inflammatory disease,
and long-term
clinical treatment often leads to side effects. In this study, we
evaluated pterostilbene (PT), a natural anti-inflammatory substance,
for its protective effects and safety during prolonged use on OA.
Results showed that PT alleviated the loss of chondrocytes and widened
the narrow joint space in an octacalcium phosphate (OCP)-induced OA
mouse model (n = 3). In vitro experiments demonstrate
that PT reduced NLRP3 inflammation activation (relative protein expression:
C: 1 ± 0.09, lipopolysaccharide (LPS): 1.14 ± 0.07, PT:
0.91 ± 0.07, LPS + PT: 0.68 ± 0.04) and the release of inflammatory
cytokines through NF-κB signaling inactivation (relative protein
expression: C: 1 ± 0.03, LPS: 3.49 ± 0.02, PT: 0.66 ±
0.08, LPS + PT: 2.78 ± 0.05), ultimately preventing cartilage
catabolism. Interestingly, PT also altered gut microbiota by reducing
inflammation-associated flora and increasing the abundance of healthy
bacteria in OA groups. Collectively, these results suggest that the
PT can be considered as a protective strategy for OA.